The EPAS1 gene helps your body sense low oxygen and adjust red blood cell production so tissues keep getting enough oxygen. This gene plays an important role in how cells adapt when oxygen levels fall. If it does not work properly, oxygen signaling can become unbalanced. Depending on the variant, this can lead to too many red blood cells, thicker blood, or certain rare tumors in hormone making cells.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the working parts of cells. Others mainly help determine when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. More detail on this topic is available in the LearnHub.
Overview
EPAS1Gene function
What if the gene works
The EPAS1 gene helps cells sense low oxygen. It supports the body’s response by helping control red blood cell production and blood vessel growth.
Risk
What if the gene does not work
Variants in the EPAS1 gene can cause extra red blood cell production, sometimes causing thick blood. Milder or more severe variants can affect timing and severity. Some are also linked to rare adrenal or nerve tissue tumors.
Treatment
What does that mean for your treatment
No EPAS1-specific treatment or management approach is currently established in clinical guidelines. The EPAS1 gene is an active drug target in cancer research because it makes HIF-2 alpha, a protein that helps cells respond to low oxygen, and drugs that block HIF-2 alpha are being studied or used in some cancers.
Conditions associated with EPAS1
Gene function
What if the gene works
Everyday activities like exercise or a stay at higher altitude can lower oxygen levels for a time. The EPAS1 gene helps your body adjust to those shifts by guiding a low oxygen response. This is how the EPAS1 gene helps your body respond to low oxygen in a steady, coordinated way. Its protein mainly works as a control switch for other genes.
Inside many tissues, the EPAS1 gene helps cells notice when oxygen is lower than usual. That early signal allows the body to start adapting before lower oxygen begins to limit normal work.
Its protein acts as a control switch that turns on a group of helpful genes during low oxygen. These genes support a coordinated response across the body.
One of its best known jobs is helping control signals that increase red blood cell production when more capacity to carry oxygen is needed. This supports oxygen delivery from the lungs to the rest of the body.
The EPAS1 gene also helps guide signals that support blood vessel growth and upkeep. This can improve how oxygen and nutrients reach tissues.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the EPAS1 gene change how cells handle the protein it makes, often making it harder to switch off or break down. This helps explain how EPAS1 gene variants affect oxygen sensing: low oxygen signals can stay active longer than usual. Milder variants may only slightly increase this activity, while more disruptive variants can raise it more strongly and may be linked to earlier or more noticeable excess red blood cell production.
How variants are linked to conditions
Pathogenic variants in the EPAS1 gene can cause familial erythrocytosis type 4, an inherited condition with too many red blood cells. The EPAS1 gene and familial erythrocytosis are the best established pairing in medical genetics. Some EPAS1 variants, often noninherited changes found only in tumor tissue, are also linked to paraganglioma or pheochromocytoma and may occur alongside polycythemia (too many red blood cells).
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Risk with EPAS1 depends a lot on the exact gene change. For inherited harmful changes, the variant itself is often the main driver, and there is not enough evidence to say lifestyle changes lower that risk; things that raise red blood cell levels, such as smoking, low oxygen, or living at high altitude, can add to related problems.
Inheritance of EPAS1 variants
EPAS1 gene inheritance depends on the condition and on whether the variant is present in the germline, meaning the DNA passed from parent to child. For inherited EPAS1-related erythrocytosis, the pattern is autosomal dominant, so a parent with the variant can pass it to each child with a 50% chance. Some EPAS1-related conditions are caused by variants that arise after conception in only part of the body, and those are usually not inherited. This is the key point when asking how variants of the EPAS1 gene are inherited.
What does my EPAS1 result mean for my family?
For EPAS1, the clearest inherited family pattern is a dominant one linked to some forms of inherited high red blood cell levels. That means close relatives, including parents, brothers, sisters, and children, may also carry the same change, and each child can have a 1 in 2 chance. In a family with this kind of EPAS1 result, relatives may want to learn whether the same gene change is present.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the EPAS1 gene, genetic testing usually uses a blood sample, saliva, or a cheek swab. A lab reads the DNA in the EPAS1 gene and compares it with the usual sequence to spot variants. Results may identify a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
EPAS1 genetic testing may be worth considering if you or close relatives have an unexplained high red blood cell count or high hemoglobin, especially from a young age. It can also help in some people with certain rare adrenal or nerve-related tumors.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Lifestyle, environment, age, and medical history, among other factors, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in the genes involved in handling drugs can change how quickly a medicine is broken down, how strongly it works, or how sensitive someone is to side effects. This is a common reason why the same treatment may help one person a lot, help another only a little, or feel harder to tolerate. Genetics is only one part of the picture, but it can play a meaningful role alongside age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can affect how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the EPAS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about medicines, side effects, or your general health are best discussed with your doctor.
History
The EPAS1 gene entered genetics research in the late 1990s, when scientists identified it while studying how the body responds to low oxygen. It was later recognized as the same gene that produces HIF-2α, linking earlier lines of research into one clearer picture. From these first observations, research expanded steadily as teams explored its role in cancer biology, blood cell production, and adaptation to life at high altitude. A major milestone came when studies of Tibetan populations showed that variants in the EPAS1 gene were strongly linked to long term high altitude adaptation. That finding made the EPAS1 gene one of the best known examples of recent human evolution. Its history now spans both laboratory discovery and population genetics.